OLPX icon

Olaplex Holdings

1.29 USD
+0.02
1.57%
Updated Apr 1, 3:39 PM EDT
1 day
1.57%
5 days
2.38%
1 month
-6.52%
3 months
-23.67%
6 months
-44.64%
Year to date
-23.67%
1 year
-33.51%
5 years
-94.73%
10 years
-94.73%
0
Funds holding %
of 7,398 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

0.64% more ownership

Funds ownership: 88.8% [Q3] → 89.44% (+0.64%) [Q4]

5% less funds holding

Funds holding: 170 [Q3] → 161 (-9) [Q4]

23% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 62

26% less capital invested

Capital invested by funds: $1.38B [Q3] → $1.03B (-$356M) [Q4]

29% less call options, than puts

Call options by funds: $375K | Put options by funds: $528K

32% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 25

50% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$1.70
32%
upside
Avg. target
$1.90
47%
upside
High target
$2
55%
upside

3 analyst ratings

positive
0%
neutral
100%
negative
0%
Telsey Advisory Group
Dana Telsey
27% 1-year accuracy
50 / 183 met price target
55%upside
$2
Market Perform
Maintained
12 Mar 2025
Barclays
Lauren Lieberman
48% 1-year accuracy
47 / 97 met price target
32%upside
$1.70
Equal-Weight
Maintained
5 Mar 2025
Piper Sandler
Korinne Wolfmeyer
31% 1-year accuracy
15 / 48 met price target
55%upside
$2
Neutral
Maintained
6 Jan 2025

Financial journalist opinion

Based on 4 articles about OLPX published over the past 30 days

Negative
Seeking Alpha
3 weeks ago
Olaplex: Competition And Patent Expiration Are Enormous Obstacles
While hair loss concerns likely caused some brand damage, Olaplex's primary issue appears to be competition. As a result of increased competition, Olaplex faces declining sales and gross margins and rising operating expenses. New management and a shift in strategy could change this situation but I am skeptical.
Olaplex: Competition And Patent Expiration Are Enormous Obstacles
Neutral
Seeking Alpha
3 weeks ago
Olaplex Holdings, Inc. (OLPX) Q4 2024 Earnings Call Transcript
Olaplex Holdings, Inc. (NASDAQ:OLPX ) Q4 2024 Earnings Conference Call March 4, 2025 9:00 AM ET Company Participants Allison Malkin – Investor Relations Amanda Baldwin – Chief Executive Officer Catherine Dunleavy – Chief Operating Officer and Chief Financial Officer Conference Call Participants Susan Anderson – Canaccord Genuity Olivia Tong – Raymond James Ashley Helgans – Jefferies Lauren Lieberman – Barclays Dana Telsey – Telsey Advisory Group Operator Greetings and welcome to Olaplex Holdings, Inc.'s Fourth Quarter 2024 Earnings Results Conference Call. At this time, all participants are in a listen-only mode.
Olaplex Holdings, Inc. (OLPX) Q4 2024 Earnings Call Transcript
Positive
Zacks Investment Research
4 weeks ago
Olaplex (OLPX) Reports Q4 Earnings: What Key Metrics Have to Say
The headline numbers for Olaplex (OLPX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Olaplex (OLPX) Reports Q4 Earnings: What Key Metrics Have to Say
Neutral
GlobeNewsWire
4 weeks ago
OLAPLEX Reports Fourth Quarter and Fiscal Year 2024 Results
NEW YORK, NY, March 04, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company") today announced financial results for the fourth quarter and fiscal year ended December 31, 2024.
OLAPLEX Reports Fourth Quarter and Fiscal Year 2024 Results
Positive
Zacks Investment Research
1 month ago
Countdown to Olaplex (OLPX) Q4 Earnings: Wall Street Forecasts for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Olaplex (OLPX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
Countdown to Olaplex (OLPX) Q4 Earnings: Wall Street Forecasts for Key Metrics
Neutral
GlobeNewsWire
1 month ago
Olaplex Holdings, Inc. Announces Participation in the Raymond James 46th Annual Institutional Investors Conference on March 5th
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (“OLAPLEX”), today announced its participation in the Raymond James 46th Annual Institutional Investors Conference being held at the JW Marriott Orlando Grande Lakes in Orlando, Florida.
Olaplex Holdings, Inc. Announces Participation in the Raymond James 46th Annual Institutional Investors Conference on March 5th
Neutral
GlobeNewsWire
1 month ago
Olaplex Holdings, Inc. to Report Fourth Quarter and Fiscal 2024 Financial Results on March 4th
NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (“OLAPLEX”), today announced that it plans to report fourth quarter and fiscal 2024 financial results before the market opens on Tuesday, March 4, 2025.
Olaplex Holdings, Inc. to Report Fourth Quarter and Fiscal 2024 Financial Results on March 4th
Positive
Seeking Alpha
2 months ago
Olaplex: A Speculative Turnaround Play
Olaplex, despite a 94% stock drop, remains profitable with positive cash flows and a strong balance sheet, making it a speculative but potentially rewarding investment. The company's reputation suffered due to allegations of hair loss from its products, leading to significant revenue declines and a challenging market perception. New management, led by an industry veteran, aims to restore Olaplex's reputation and business, with a strategic plan expected in early 2025.
Olaplex: A Speculative Turnaround Play
Neutral
Finbold
4 months ago
‘Big Short' Michael Burry stock portfolio update
After the famous ‘Big Short' investor Michael Burry abandoned his 2023 bet against the semiconductor industry – though, interestingly, the short position may not have been wrong, only poorly timed – he again stirred controversy with his persistent bullishness about Chinese stocks.
‘Big Short' Michael Burry stock portfolio update
Positive
Seeking Alpha
4 months ago
Olaplex: Lashbond Building Serum Market Is Another Reason To Buy
Olaplex Holdings has shown strong financial performance from 2020 to 2023, with significant growth potential driven by new investments and global distribution expansions. The company is undervalued, currently trading below $2 per share, despite a fair valuation estimate of $7 per share under normal circumstances. Key growth drivers include the Lashbond Building Serum Market, international distributor agreements, and innovation through partnerships with universities and biotech companies.
Olaplex: Lashbond Building Serum Market Is Another Reason To Buy
Charts implemented using Lightweight Charts™